全球近视性黄斑变性相关视觉损害的患病率及2000年至2050年时间趋势:系统评价、Meta分析与建模
该研究通过系统评价与Meta分析纳入17项研究共137514名参与者,量化近视性黄斑变性(MMD)相关盲与视觉损害(VI),并基于卫生支出模型预测全球患病率。结论认为MMD导致的盲与VI负担将显著上升。
要点
- 基于卫生支出的模型与MMD VI和盲数据相关性最佳,用于分国家分年代估计。
核心结论
- 若不努力减少近视的发生与进展并改善MMD管理,MMD所致盲与视觉损害的负担将显著上升。
研究设计与样本
- 系统评价与Meta分析,纳入17篇符合入选标准的MMD视觉损害患病率数据论文,共137514名参与者;其中6篇提供年龄别数据,按相对年龄依赖风险标化后在VI和盲水平进行Meta分析;对全部MMD VI和盲数据占高度近视的比例与数据收集地点和年份变量进行分析,基于卫生支出的模型相关性最佳,并用于估计各国每十年的患病率和人数。
关键数值与推荐
- 系统评价识别出17篇符合入选标准的MMD视觉损害患病率数据论文。
- 6篇论文提供年龄别数据,按相对年龄依赖风险标化后在VI和盲水平进行Meta分析。
- 基于卫生支出的模型对MMD VI和盲数据占高度近视比例与地点和年份变量的相关性最佳。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: We used systematic review and meta-analysis to identify and assimilate evidence quantifying blindness and visual impairment (VI) associated with myopic macular degeneration (MMD), then derived models to predict global patterns. The models were used to estimate the global prevalence of blindness and VI associated with MMD from 2000 to 2050. METHODS: The systematic review identified 17 papers with prevalence data for MMD VI fitting our inclusion criteria. Data from six papers with age-specific data were scaled to relative age-dependent risk and meta-analysed at VI and blindness levels. We analysed variance in all MMD VI and blindness data as a proportion of high myopia against variables from the place and year of data collection, with a model based on health expenditure providing the best correlation. We used this model to estimate the prevalence and number of people with MMD VI in each country in each decade. RESULTS: We included data from 17 studies comprising 137 514 participants. We estimated 10.0 million people had VI from MMD in 2015 (prevalence 0.13%, 95% CI 5.5 to 23.7 million, 0.07% to 0.34%), 3.3 million of whom were blind (0.04%, 1.8 to 7.8 million, 0.03% to 0.10%). We estimate that by 2050, without changing current interventions, VI from MMD will grow to 55.7 million people (0.57%, 29.0 to 119.7 million, 0.33% to 1.11%), 18.5 million of whom will be blind (0.19%, 9.6 to 39.7 million, 0.11% to 0.37%). CONCLUSION: The burden of MMD blindness and VI will rise significantly without efforts to reduce the development and progression of myopia and improve the management of MMD.
引用
- Fricke TR, Jong M, Naidoo KS, et al. Global prevalence of visual impairment associated with myopic macular degeneration and temporal trends from 2000 through 2050: systematic review, meta-analysis and modelling. Br J Ophthalmol. 2018. PMID: 29699985. doi:10.1136/bjophthalmol-2017-311266
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。